1.41 USD
↘ 0.44 (23.80%)AT CLOSE (03:59 PM EDT)
XORTX Therapeutics Inc. Common Stock
XRTXNASDAQ • USD
1.72
↗ 0.31 (22.06%)
POST MARKET (AS OF 06:07 PM EDT)
Post Market
AS OF 06:07 PM EDT
1.72
↗ 0.31 (22.06%)
Market: OPEN
XORTX Therapeutics Inc. Common Stock (XRTX) trades at $1.72 per share. Technical indicators currently signal "Strong Sell". Notable factors include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 9, 2026.
Open?$2.05
High?$2.08
Low?$1.36
Prev. Close?$1.85
Volume?18.4M
Avg. Volume?N/A
VWAP?$2.04
Bid / Ask
Bid?$1.21 × 100
Ask?$1.62 × 100
Spread?$0.41
Midpoint?$1.42
Valuation & Ratios
Market Cap?3.4M
Shares Out?1.8M
Float?1.7M
Float %?96.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?3.52%Low
Short Interest?61.5K
Days to Cover?1.0
Free Float1.7M
Avg Daily Volume910.8K
Settlement Date2026-09-30